Yubo International Biotech Ltd (YBGJ)
Yubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a diverse range of products, including solutions for respiratory health, skincare and hair care formulations, nutritious beverages, and personal care items tailored for both men and women. Furthermore, it delivers specialized stem cell services, such as cellular analysis and comprehensive health management consulting, all offered under the VIVCELL brand. The company's headquarters are located in Beijing, China.
Sector: Electromedical & Electrotherapeutic Apparatus
Industry: Medical - Instruments & Supplies
Yubo International Biotech Limited
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
CNYubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a diverse range of products, including solutions for respiratory health, skincare and hair care formulations, nutritious beverages, and personal care items tailored for both men and women. Furthermore, it delivers specialized stem cell services, such as cellular analysis and comprehensive health management consulting, all offered under the VIVCELL brand.
The company's headquarters are located in Beijing, China.
Leadership
Jun Wang
President & Director
Lina Liu
Chief Financial Officer, Treasurer, Secretary & Director
Yang Wang
Chief Executive Officer & Director
Jin Wei
Co-Owner
Employees
18
Country
CN
Sector
Healthcare
Website
yubogroup.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Wang Jun | President | Grant/Award | 42.00M | $2.10M | Jul 23, 2025 |
 Wang Yang | Chief Executive Officer | Grant/Award | 8.60M | $430.0K | Jul 23, 2025 |
| Wang Yang | Chief Executive Officer | Sale | 2.00M | $240.0K | Jul 15, 2024 |
 Boao Biotech Ltd | 10% Owner | Sale | 741.5K | $222.5K | Jan 25, 2024 |
| Boao Biotech Ltd | 10% Owner | Sale | 301.7K | $90.5K | Jan 25, 2024 |
| Boao Biotech Ltd | 10% Owner | Sale | 364.4K | $109.3K | Jan 25, 2024 |
| Name | Shares | % | Source |
|---|---|---|---|
Flydragon International Ltd · may incl. warrants· filed Jul 2025 | 81.9M | 48.1% | 13D |
Chinaone Technology Ltd · may incl. warrants· filed Jul 2025 | 25.8M | 15.1% | 13D |
Boao Biotech Ltd · may incl. warrants· filed Jun 2025 | 19.9M | 16.6% | 13G |
Insiders
- Wang JunPresident
- Wang YangChief Executive Officer
- Boao Biotech Ltd10% Owner
CN30d Avg
1.00K
60d Avg
15.42K
90d Avg
12.30K